Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.
暂无分享,去创建一个
Antonio Núñez Galindo | J. Wojcik | M. Kussmann | L. Dayon | E. Migliavacca | H. Henry | J. Popp | O. Cominetti | G. Bowman | Aikaterini Oikonomidi
[1] S. Gygi,et al. Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy , 2019, Front. Neurosci..
[2] Loïc Dayon,et al. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification. , 2018, Journal of proteome research.
[3] J. Wojcik,et al. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults , 2018, Alzheimer's & Dementia.
[4] L. Dayon,et al. Identification of Missing Proteins in Normal Human Cerebrospinal Fluid. , 2018, Journal of proteome research.
[5] K. Blennow,et al. Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers , 2018, Journal of cellular and molecular medicine.
[6] J. Wojcik,et al. Alzheimer disease pathology and the cerebrospinal fluid proteome , 2018, Alzheimer's Research & Therapy.
[7] Christopher Fowler,et al. Systematic Evaluation of the Use of Human Plasma and Serum for Mass-Spectrometry-Based Shotgun Proteomics. , 2018, Journal of proteome research.
[8] A. Astrup,et al. The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention , 2018, Proteomics. Clinical applications.
[9] S. Misra,et al. Blood‐based protein biomarkers for stroke differentiation: A systematic review , 2017, Proteomics. Clinical applications.
[10] Matthias Mann,et al. Revisiting biomarker discovery by plasma proteomics , 2017, Molecular systems biology.
[11] J. Wojcik,et al. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults , 2017, Brain, Behavior, and Immunity.
[12] M. Laakso,et al. The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology , 2017, Alzheimer's Research & Therapy.
[13] D. Galasko,et al. Alzheimer disease: CSF biomarkers for Alzheimer disease — approaching consensus , 2017, Nature Reviews Neurology.
[14] P. Snyder,et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic , 2017, Alzheimer's & Dementia.
[15] Matthias Mann,et al. Proteomics reveals the effects of sustained weight loss on the human plasma proteome , 2016, Molecular systems biology.
[16] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[17] Cathy H. Wu,et al. UniProt: the universal protein knowledgebase , 2016, Nucleic Acids Research.
[18] Juan Antonio Vizcaíno,et al. The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition , 2016, Nucleic Acids Res..
[19] Ruedi Aebersold,et al. Mass-spectrometric exploration of proteome structure and function , 2016, Nature.
[20] J. Wojcik,et al. A NEUROINFLAMMATORY BIOMARKER SIGNATURE OF BLOOD-BRAIN BARRIER IMPAIRMENT IN OLDER ADULTS , 2016, Alzheimer's & Dementia.
[21] E. Diamandis,et al. Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas , 2016, Clinical Proteomics.
[22] Loïc Dayon,et al. Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry. , 2016, Journal of proteome research.
[23] José A. Dianes,et al. 2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..
[24] M. Kussmann,et al. Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery. , 2015, Analytical chemistry.
[25] Yajie Wang,et al. A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome. , 2015, Journal of proteomics.
[26] Ruedi Aebersold,et al. Quantitative variability of 342 plasma proteins in a human twin population , 2015 .
[27] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[28] J. Mulder,et al. Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis. , 2014, Journal of proteome research.
[29] M. Kussmann,et al. Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. , 2014, Journal of proteome research.
[30] A. C. Kroksveen,et al. Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome , 2014, PloS one.
[31] Sara Hall,et al. Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment , 2013, Brain, Behavior, and Immunity.
[32] G. Kokwaro,et al. Plasma and Cerebrospinal Proteomes From Children With Cerebral Malaria Differ From Those of Children With Other Encephalopathies , 2013, The Journal of infectious diseases.
[33] A. Baker,et al. Application of Blood-Based Biomarkers in Human Mild Traumatic Brain Injury , 2013, Front. Neurol..
[34] J. Trojanowski,et al. Relationship between CSF and plasma proteomic data in the ADNI-1 cohort , 2012, Alzheimer's & Dementia.
[35] R. Tibshirani,et al. Regression shrinkage and selection via the lasso: a retrospective , 2011 .
[36] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[37] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[38] Richard D. Smith,et al. Establishing the Proteome of Normal Human Cerebrospinal Fluid , 2010, PloS one.
[39] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[40] J. Kaye,et al. Blood–brain barrier impairment in Alzheimer disease , 2007, Neurology.
[41] F. Jessen,et al. [Diagnostic lumbar puncture performed in the outpatient setting of a memory clinic. Frequency and risk factors of post-lumbar puncture headache]. , 2007, Der Nervenarzt.
[42] N. Gilhus,et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force , 2006, European journal of neurology.
[43] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[44] M. Cavaglià,et al. Peripheral markers of blood-brain barrier damage. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[45] D. Porte,et al. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans , 1996, Nature Medicine.
[46] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[47] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.
[48] G. Tibbling,et al. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. , 1977, Scandinavian journal of clinical and laboratory investigation.
[49] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[50] Loïc Dayon,et al. Relative Protein Quantification by MS/MS Using the Tandem Mass Tag Technology , 2012, Quantitative Methods in Proteomics.
[51] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.